男性伴侣治疗对复发性细菌性阴道病复发的影响:随机双盲安慰剂对照试验
这项多中心、双臂、双盲、安慰剂对照试验纳入214对夫妇,女性均患复发性细菌性阴道病(BV)并接受7天多剂量甲硝唑治疗,男性伴侣随机接受安慰剂或7天多剂量甲硝唑。
要点
- 男性伴侣多剂量甲硝唑治疗未显著降低女性BV复发率。
- 男性伴侣依从用药与女性治疗失败风险降低相关。
- 该关联在甲硝唑组的post hoc比较中持续存在。
核心结论
- 整体上,男性伴侣接受7天多剂量甲硝唑治疗未显著降低女性伴侣的BV复发。
研究设计与样本
- 多中心、双臂、双盲、安慰剂对照研究,共纳入214对夫妇。
- 女性接受7天多剂量甲硝唑治疗,男性伴侣随机接受安慰剂或7天多剂量甲硝唑,并要求14天避免无保护性行为。
- 女性随访在第21天及第8、16周进行,男性随访在第14-21天进行。
主要发现
- 意向治疗人群中,主要结局在两组间无显著差异。
- 至第三次随访,甲硝唑组和安慰剂组女性BV治疗失败率分别为81%和80%(P > .999)。
- 该发现在甲硝唑组的post hoc比较中持续存在。
关键数值与推荐
- BV治愈定义为女性伴侣Amsel标准0-2项且Nugent评分0-6,主要终点在第16周。
- 男性伴侣方案为多剂量甲硝唑2次/天共7天。
- 临床试验注册号NCT02209519。
临床怎么用
- 结果不支持对所有复发性BV女性的男性伴侣常规使用多剂量甲硝唑以降低复发。
- 男性伴侣用药依从性与女性治疗失败风险降低相关,提示依从性可能是影响疗效的重要因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to determine if treatment of male sexual partners of women with recurrent bacterial vaginosis (BV) with oral metronidazole 2×/day for 7 days (ie, multidose metronidazole) significantly decreased BV recurrence rates in the female. METHODS: This was a multicenter, 2-arm, double-blind, placebo-controlled study. Women with recurrent BV and current diagnosis of BV by Amsel and Nugent were enrolled. Multidose metronidazole for 7 days was dispensed to women. Male partners were randomized to placebo versus multidose metronidazole for 7 days and asked to refrain from unprotected sex for 14 days. Female follow-up visits were conducted at day 21 and 8 and 16 weeks. Male follow-up visits occurred at days 14-21. BV cure was defined as 0-2 Amsel criteria and Nugent score 0-6 in the female partner with the primary endpoint at 16 weeks. RESULTS: 214 couples were enrolled. In the intent-to-treat population, there was no significant difference between treatment arms for the primary outcome. BV treatment failure occurred in 81% and 80% of women in the metronidazole and placebo arms through the third follow-up visit, respectively (P > .999). However, women whose male partners adhered to study medication were less likely to fail treatment (adjusted relative risk, .85; 95% CI, .73-.99; P = .035). This finding persisted in post hoc comparisons in the metronidazole arm. CONCLUSIONS: Overall, this study did not find that male partner treatment with multidose metronidazole significantly reduces BV recurrence in female partners, although women whose partners adhered to multidose metronidazole were less likely to fail treatment. CLINICAL TRIALS REGISTRATION: (NCT02209519).
引用
- Schwebke JR, Lensing SY, Lee J, et al. Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis. 2021. PMID: 33383580. doi:10.1093/cid/ciaa1903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。